In Alzheimer’s disease, the decrease of NAD+ levels has been shown to be associated with decreased activity of nicotinamide phosphoribosyltransferase (NAMPT) [34]. The gene discussed is NAMPT; the disease is early-onset autosomal dominant Alzheimer disease.